Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Sponsor: Brigham and Women's Hospital
Summary
To perform an observational analysis to emulate a target trial (i.e., a hypothetical pragmatic trial that would have answered the causal question of interest) comparing the effectiveness and safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide 1 receptor agonists (GLP-1RA), dipeptidyl peptidase-4 inhibitors (DPP-4i), and sulfonylureas (SU), at the class and individual agent level, in head-to-head comparisons in patients with type 2 diabetes (T2D).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
781430
Start Date
2021-08-01
Completion Date
2026-07-01
Last Updated
2025-12-08
Healthy Volunteers
No
Interventions
SGLT2 inhibitor
Any SGLT2i dispensing claim
DPP-4 inhibitor
Any DPP-4 inhibitor claim
GLP-1RA
Any SGLT2i dispensing claim
2nd generation SU
Any 2nd generation SU claim
Locations (1)
Brigham and Women's Hospital
Boston, Massachusetts, United States